Lucillia Bezu

16PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 01, 2025
Immuno-oncological effects of the α2-adrenoceptor agonist dexmedetomidine.

Lucillia Bezu, Oliver Kepp, Guido Kroemer

|Jun 06, 2025
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade.

Liwei Zhao, Peng Liu, Allan Sauvat

|Jan 08, 2025
The effect of the type of anaesthesia on long-term outcomes after cancer resection surgery: a narrative review.

Lucillia Bezu, Lua S Rahmani, Donal J Buggy

|Nov 22, 2024
High circulating HMGB1 indicates good prognosis in patients with advanced leiomyosarcoma under chemoimmunotherapy.

Lucillia Bezu, Guido Kroemer

|Aug 29, 2024
Impact of Surgical and Anesthetic Procedures after Colorectal Cancer Surgery: A Propensity Score-Matched Cohort Study (The PROCOL Study).

Céline Kuoch, Lucillia Bezu

|Jul 13, 2024
Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review.

Lucillia Bezu, Dilara Akçal Öksüz, Max Bell

Pageof 3

Frequent Collaborators

9 joint publications

Oliver Kepp

8 joint publications

Guido Kroemer

2 joint publications

Jonathan Pol

2 joint publications

Donal J Buggy